Louise Bordeleau

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

Kelly Metcalfe, Andrea Eisen, Leigha Senter et al. · British Journal of Cancer · 2019 · 179 citations · Full text

Medicine, Genetics, Oncology +17

Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.

Reuben Broom, Patricia A. Tang, Christine Simmons et al. · PubMed · 2009 · 153 citations

Medicine, Oncology, Pathology +15

Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing Data

Louise Bordeleau, John Paul Szalai, Marguerite Ennis et al. · Journal of Clinical Oncology · 2003 · 150 citations

Medicine, Oncology, Breast Oncology +16

Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors

Louise Bordeleau, Kathleen I. Pritchard, Charles L. Loprinzi et al. · Journal of Clinical Oncology · 2010 · 129 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12